GGrantIndex
← Leaderboards

University Of Toronto

Toronto, ON

Compare ↔
$90,382,883
Total funding
93
Grants

Funding over time

peak $5.1M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$88,867,812 · 89
NSF$1,289,332 · 3
CDC$225,739 · 1

By mechanism

R01$62,405,866 · 50
U01$11,691,737 · 2
R21$5,535,216 · 22
R25$3,278,536 · 1
R37$2,778,981 · 1
R61$1,329,349 · 1

Investigators at University Of Toronto

Largest grants

Development and testing of polyvalent anthrax toxin inhibitors$1,278,409
U01 · FY2012 · AI
Development and testing of polyvalent anthrax toxin inhibitors$1,257,524
U01 · FY2011 · AI
Development and testing of polyvalent anthrax toxin inhibitors$1,214,722
U01 · FY2008 · AI
Development and testing of polyvalent anthrax toxin inhibitors$1,174,989
U01 · FY2010 · AI
Development and testing of anthrax toxin inhibitors$1,162,269
U01 · FY2006 · AI
Development and testing of anthrax toxin inhibitors$1,162,003
U01 · FY2007 · AI
Development and testing of anthrax toxin inhibitors$1,155,989
U01 · FY2005 · AI
Development and testing of polyvalent anthrax toxin inhibitors$1,153,320
U01 · FY2009 · AI
Development and testing of anthrax toxin inhibitors$1,122,727
U01 · FY2004 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$817,242
R01 · FY2017 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$804,411
R01 · FY2016 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$796,231
R01 · FY2018 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$777,729
R01 · FY2019 · AI
Programs at the Fields Institute for Research in Mathematical Sciences$750,000
· FY2018 · MPS
Development and testing of anthrax toxin inhibitors$748,200
U01 · FY2003 · AI
Mapping the reference genetic network of a eukaryotic cell$665,015
R01 · FY2011 · HG
Mapping the reference genetic network of a eukaryotic cell$665,015
R01 · FY2012 · HG
Mapping the reference genetic network of a eukaryotic cell$663,319
R01 · FY2010 · HG
Targeting Hsp90 in cryptococcal fungal pathogenesis$655,235
R01 · FY2023 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$653,100
R01 · FY2024 · AI